Drug lookup
Drug reference

Isoflurane

General Anesthetic · Anaesthetic

Also known as AErrane

General AnestheticAnaesthetic
CDSCO approved
EXCRETION
not curated
INTERACTIONS
8 major
SEVERE in our sources
PREGNANCY
May depress neonatal respiration if used during delivery.
FDA category + note
Top interactionssee all 12
  • DroperidolSevereDatabaseDDInter
  • EpinephrineSevereDatabaseDDInter
  • IsocarboxazidSevereDatabaseDDInter
  • NorepinephrineSevereDatabaseDDInter

Mechanism

Isoflurane is a halogenated methyl ethyl ether volatile anesthetic with a MAC of 1.15% that potentiates GABA-A receptor-mediated inhibition and attenuates glutamate-mediated excitation. It produces dose-dependent decreases in mean arterial pressure primarily through peripheral vasodilation, with relatively preserved cardiac output compared to halothane. Isoflurane undergoes minimal hepatic metabolism (0.2%), producing negligible fluoride ion release and making it the least hepatotoxic of the halogenated agents.

Indications

Induction of anaesthesiaMaintenance of anaesthesiaMaintenance of anaesthesia in caesarean sectionmaintenance of anesthesia

Dosing

Adult
For induction of anaesthesia (in oxygen or nitrous oxide–oxygen): Initially 0.5 %, increased to 3 %, adjusted according to response, administered using specifically calibrated vaporiser. For maintenance of anaesthesia (in nitrous oxide–oxygen): 1–2.5 %, to be administered using specifically calibrated vaporiser; an additional 0.5–1% may be required when given with oxygen alone.…

Pharmacokinetics

Excretion
more than 99% excreted unchanged by the lungs

Side effects

Common
Carboxyhaemoglobinaemiachest discomfortcognitive impairmentdeliriumdyspnoeaileusmood altered (that can last several days)myoglobinuriaskin reactionshypotensionconcentration-dependent decrease in arterial blood pressurevasodilation (especially in skin and muscle)transient tachycardia and hypertension (with rapid changes in concentration due to sympathetic stimulation)concentration-dependent depression of ventilationairway irritant (coughing, laryngospasm)relaxation of skeletal musclerelaxation of uterine smooth musclereduces renal blood flow and glomerular filtration rate (GFR)
Serious
  • modest risk of increased intracranial pressure (ICP) in patients with preexisting intracranial hypertension

Pregnancy & lactation

Pregnancy

May depress neonatal respiration if used during delivery.

Lactation

Breast-feeding can be resumed as soon as mother has recovered sufficiently from anaesthesia.

Drug interactions

Droperidol
Severe
Database

Clinical effect not specified

Source: DDInter

Epinephrine
Severe
Database

Drug interaction classified as: others.

Source: DDInter

Isocarboxazid
Severe
Database

Clinical effect not specified

Source: DDInter

Norepinephrine
Severe
Database

.

Source: DDInter

Phenelzine
Severe
Database

Clinical effect not specified

Source: DDInter

Selegiline
Severe
Database

Clinical effect not specified

Source: DDInter

Sodium Oxybate
Severe
Database

Clinical effect not specified

Source: DDInter

Tranylcypromine
Severe
Database

Clinical effect not specified

Source: DDInter

Competitive Blockers
Moderate
Textbook

Increased neuromuscular blockade from competitive blockers.

Source: KDT 7e · p347-359

Competitive Neuromuscular Blocker
Moderate
Textbook

Enhanced neuromuscular blockade.

The dose of competitive neuromuscular blocker may need to be 1/3–1/2 of the figure given for opioid/nitrous oxide + oxygen anaesthesia.

Source: KDT 7e · Table 25.2 footnote

Isoniazid
Moderate
Database

Decreased effectiveness of isoflurane.

Not explicitly stated.

Source: DDInter

Succinylcholine
Moderate
Database

Phase II blockade by succinylcholine; malignant hyperthermia.

Source: DDInter

Related guidelines

Other General Anesthetic drugs

Ask House about Isoflurane

Continue into a citation-backed clinical answer with the drug context already attached.

Sources: Goodman & Gilman 14e, Katzung·Verified: 2026-05-13 · House clinical team